Investigating new treatments for infectious diseases through early clinical trials
Task A: Early Phase Clinical Trial Units (EPCTU)
This study is looking for patients to help test new treatments for infectious diseases, so we can find safer and more effective ways to fight these illnesses and get new therapies to people faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ppd Development LP NIH-funded |
| Lab location | 1 site (Wilmington, United States) |
| Project ID | NIH-11259398 on NIH RePORTER |
What this research studies
This research focuses on the Early Phase Clinical Trial Units, which are designed to investigate new agents for treating and preventing infectious diseases. The approach involves implementing interventional clinical trials that assess the effectiveness and safety of these new treatments. Patients may have the opportunity to participate in trials that explore innovative therapies aimed at combating various infectious diseases. The research aims to streamline the clinical trial process to bring new treatments to patients more efficiently.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals suffering from infectious diseases who are seeking new treatment options.
Not a fit: Patients with non-infectious diseases or those who do not meet the specific criteria for the trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have performed: Other research has shown success with similar early phase clinical trial approaches, indicating a promising avenue for developing new treatments.
Where this research is happening
Wilmington, United States
- Ppd Development LP — Wilmington, United States (Active)
Researchers
- Principal investigator: Palleja, Sandra — Ppd Development LP
- Study coordinator: Palleja, Sandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.